This newslink doesn't exist or it was removed.
Go to Homempage.
Ars Technica USA Science December 27, 2023
Navigate Filter by topic Settings Front page layout Site theme - Dec 27, 2023 2:57 pm UTC / Smart insulin has the potential to make injections far less frequent. People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain... + más
Insulin Isn’t the Only High Cost for Diabetes Patients | Time
FitBit, Apple Watch, glucose monitors, sweat patch: Which wellness tracker is right for you? | The Advocate
NBC News USA Nation March 01, 2023
When Rena Rossi, 41, was diagnosed with a rare type of diabetes at age 36, one of the first things she did was seek out other people living with the illness. The easiest way to do that was through social media and online groups dedicated to diabetes. The groups she joined and... + más
California latest to sue drug companies over insulin prices | ABC7
Eli Lilly caps out-of-pocket costs for insulin effective immediately | Fox Business
Fox Business USA Business March 02, 2023
Arkansas Attorney General Leslie Rutledge provides insight into the conditions at the southern border as Title 42 is set to end and suing major pharma companies over raising the price of insulin. Eli Lilly is capping out-of-pocket costs for its insulin at $35 for patients,... + más
Eli Lilly To Lower Insulin Prices And Introduce A $35 Out-Of-Pocket Monthly Cap For Commercially Insured And Uninsured Diabetics | Forbes
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions | NBC News
CNBC USA Health February 09, 2023
President Joe Biden delivers the State of the Union address to a joint session of Congress on Feb. 7, 2023Pool Getty ImagesPresident used the bully pulpit during the State of the Union address this week to call for a universal price cap on insulin for all diabetes patients but... + más
California Joins Other States in Suing Companies Over Insulin Prices | The New York Times
ABC7 USA Health January 13, 2023
People are losing their lives because they can't afford the drug, Bonta said.Daphne Dorsey, associate director for media relations for Eli Lilly, said the company is disappointed by the California Attorney General's false accusations. She said the average... + más
More than 1 million Americans ration their insulin as the drug's cost skyrockets | CBS News
About iurex | Privacy Policy | Disclaimer |